Oct 31 • General discussion
🚀 New Inhaler Guidance AIR & MART Therapy: Better Asthma Control for Our Patients
There have been some important updates to asthma management, with a shift towards using AIR (Anti-Inflammatory Reliever) and MART (Maintenance and Reliever Therapy) inhaler strategies. These approaches are helping simplify treatment and improve outcomes for our patients.
💡 What’s New?
Traditional asthma management often relied on separate inhalers:
- A preventer (usually a corticosteroid) used daily, and
- A reliever (usually salbutamol) used as needed for symptoms.
However, new evidence supports combining these roles using a single combination inhaler that includes both an inhaled corticosteroid (ICS) and a fast-acting long-acting beta agonist (LABA) like formoterol.
🌬️ AIR (Anti-Inflammatory Reliever)
AIR therapy uses an ICS/formoterol inhaler as needed, rather than a SABA alone. This provides immediate relief from symptoms and delivers anti-inflammatory medication at the same time addressing both symptoms and underlying inflammation early.
Benefits:
- Fewer severe exacerbations
- Reduced need for oral steroids
- Lower hospital admissions
- Simplified treatment (one inhaler as needed)
⚖️ MART (Maintenance and Reliever Therapy)
MART takes it one step further patients use the same ICS/formoterol inhaler for both daily maintenance and symptom relief.
Benefits:
- Improved overall asthma control
- Fewer flare-ups and emergency visits
- Easy to use and reduces confusion with multiple inhalers
- Tailored dosing patients naturally use more steroid when their symptoms worsen
👏 Why This Matters
These strategies put anti-inflammatory treatment at the centre of asthma care. They empower patients, reduce reliance on blue relievers, and improve long-term outcomes.
✅ Key Takeaway
“One inhaler, smarter control.”AIR and MART therapies simplify asthma management while providing better protection and flexibility for patients.
If you are turning up to patients in their homes and you see this inhalers and no salbutamol inhalers do not worry this is actually beneficial for the patients they receive the more needed steroid inhaler with a longer acting beta-2 Agonist.
This is the latest info: New asthma guidelines infographic - FINAL
2
3 comments
🚀 New Inhaler Guidance AIR & MART Therapy: Better Asthma Control for Our Patients
powered by
skool.com/paramedical-8983
A group committed to supporting your growth not only as a paramedic or clinician, but as a well-rounded student and healthcare professional.
Suggested communities
Powered by